Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
We recently published a list of Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently. In this article, we are going to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Died suddenly on 22nd December 2024. A dear son, beloved dad and brother. A funeral service will be held for Grant on ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...